Trials / Active Not Recruiting
Active Not RecruitingNCT06550024
SakuraBead Used as Resorbable Embolic for Genicular Artery Embolization
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 89 (estimated)
- Sponsor
- CrannMed · Industry
- Sex
- All
- Age
- 40 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
An open label, prospective, two-arm, multicenter, randomized controlled trial comparing SakuraBead genicular artery embolization (GAE) with a control (corticosteroid injection).
Detailed description
To compare safety and efficacy of SakuraBead with corticosteroid injection for the treatment of pain secondary to knee osteoarthritis. Treatment will be performed on a total of approximately 89 patients who will be followed up for a period of 2 years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | SakuraBead Resorbable Microspheres | Temporary Embolization of Genicular Arteries using SakuraBead Resorbable Microspheres |
| DRUG | Corticosteroid Injection | Corticosteroid injection in the knee |
Timeline
- Start date
- 2024-11-28
- Primary completion
- 2026-10-01
- Completion
- 2028-10-01
- First posted
- 2024-08-12
- Last updated
- 2026-03-18
Locations
8 sites across 4 countries: United States, Georgia, United Kingdom, Uzbekistan
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06550024. Inclusion in this directory is not an endorsement.